?
MAO-B inhibitors (Rasagiline and Selegiline) are classified as neuro-protective drugs. This means that the DA concentration levels in the central nervous system are increased.
The importance of MAO-B inhibitors is that they prolong the duration of the effects of Levodopa.
Catechol-O-methyltransferase (COMT) Inhibitors
1. Mechanism of action:
Entacapone and tolcapone are inhibitors of COMT, the enzyme in both the CNS and peripheral
tissues that convert levodopa to 3OMD.
Increased plasma levels of 3OMD are associated with poor response to levodopa partly because the compound competes with levodopa for active transport into the CNS.
Entacapone acts only in the periphery.
This drug inhibits DA2 functioning by antagonising adenosine activity, preventing the inhibition of dopamine functions. It is an additional therapy to L-dopa or carbidopa therapy that experiences on-off episodes.
Safinamide increases DA activity, this results in the potent reversible inhibition of MAO-B and results in the inhibition of DA.